

ClinChoice
"A global CRO accelerating drug development from early trials to regulatory approval"
About ClinChoice
ClinChoice is a full service contract research organisation specialising in clinical development and lifecycle management for pharmaceutical, biotechnology, and medical device companies. With over 30 years of experience and 3,000 global experts, the company delivers end-to-end solutions across early trials, regulatory submissions, post-marketing studies, and functional services. The company serves life sciences innovators with quality-driven research services, speed, and global reach. More than 60 per cent of clients are emerging biotech firms, though it also partners with six of the top 10 global pharmaceutical companies. Therapeutic expertise spans oncology, immunology, cardiometabolic conditions, and central nervous system disorders.


3000
Team Members
1995
Founded
Series D+
Funding
Hybrid
Work Environment
A world where innovative therapies reach patients faster through efficient, high quality clinical research that removes barriers between drug discovery and regulatory approval.
At ClinChoice, our mission is to contribute to a healthier and safer world by accelerating the development and commercialisation of innovative drugs and devices.